PROM1 and glioblastoma: Furthermore, we found that mahanine-treated GBM stem-like cells were unable to form neurospheres (Figure 6c), exhibited reduced CD133+ cells in culture (Figure 6d) and exhibited dose-dependent cytotoxicity as determined by increased PI positivity (Figure 6e) with minimum toxicity to normal stem-like cells (Figure 6f).